Skip to main content
. Author manuscript; available in PMC: 2016 Jul 6.
Published in final edited form as: JAMA. 2015 Dec 22;314(24):2654–2662. doi: 10.1001/jama.2015.17296

Table 3. Within initiated treatment cycle live-birth rates and cumulative live-birth rate across all cycles in 153,360 women, undergoing 250,175 cycles of IVF using their own oocytes, stratified by age at first ovarian stimulation cycle.

Cycle number N Cycles N live-births Live-birth rate within each cycle % (95%CI) Cumulative live-birth across all cycles using different estimates % (95%CI)
Optimal estimatea Previous oocyte yield-adjusted estimateb Prognostic-adjusted estimatec Conservative estimated
Aged less than 40 years
1st 133,379 43,019 32.3 (32.0, 32.5) 32.3 (32.0, 32.5) 32.3 (32.0, 32.5) 32.3 (32.0, 32.5) 32.3 (32.0, 32.5)
2nd 53,568 14,532 27.1 (26.8, 27.5) 50.6 (50.3, 50.9) 50.7 (50.4, 51.1) 48.7 (48.4, 49.0) 44.3 (44.0, 44.5)
3rd 19,719 4,793 24.3 (23.7, 24.9) 62.6 (62.3, 63.0) 62.7 (62.3, 63.1) 58.0 (57.7, 58.4) 48.6 (48.4, 48.9)
4th 6,641 1,419 21.4 (20.4, 22.4) 70.6 (70.1, 71.1) 70.5 (70.1, 71.0) 63.3 (62.9, 63.7) 50.1 (49.8, 50.3)
5th 2,357 449 19.0 (17.5, 20.6) 76.2 (75.6, 76.8) 76.0 (75.4, 76.6) 66.4 (66.0, 66.9) 50.6 (50.3, 50.8)
6th 882 150 17.0 (14.5, 19.5) 80.3 (79.5, 81.0) 80.1 (79.3, 80.8) 68.4 (67.8, 68.9) 50.7 (50.5, 51.0)
7th 335 58 17.3 (13.3, 21.4) 83.7 (82.7, 84.7) 83.4 (82.4, 84.4) 69.8 (69.1, 70.4) 50.8 (50.5, 51.1)
8th 131 25 19.1 (12.4, 25.8) 86.8 (85.4, 88.2) 86.5 (85.1, 87.9) 70.9 (70.1, 71.6) 50.9 (50.6, 51.1)
9th 51 10 19.6 (8.7, 30.5) 89.4 (87.6, 91.2) 88.8 (87.2, 90.3) 71.6 (70.8, 72.5) 50.9 (50.6, 51.2)
Aged 40 to 42 years
1st 15,561 1,914 12.3 (11.8, 12.8) 12.3 (11.8, 12.8) 12.3 (11.8, 12.8) 12.3 (11.8, 12.8) 12.3 (11.8, 12.8)
2nd 6,671 671 10.1 (9.3, 10.8) 21.1 (20.3, 21.9) 20.8 (20.0, 21.6) 19.8 (19.1, 20.6) 16.8 (16.3, 17.4)
3rd 2,579 223 8.6 (7.6, 9.7) 27.9 (26.8, 29.1) 27.6 (26.5, 28.7) 24.7 (23.8, 25.6) 18.5 (17.8, 19.1)
4th 884 69 7.8 (6.0, 9.6) 33.6 (31.9, 35.2) 33.0 (31.4, 34.7) 28.0 (26.9, 29.2) 19.0 (18.4, 19.6)
5th 301 16 5.3 (2.8, 7.9) 37.4 (34.8, 39.4) 36.5 (34.3, 38.8) 29.7 (28.3, 31.1) 19.1 (18.5, 19.8)
6th 130 9 6.9 (2.6, 11.3) 41.5 (38.0, 44.9) 40.5 (37.3, 43.8) 31.5 (29.7, 33.3) 19.2 (18.6, 19.8)
7th 60 2 3.3 43.4 (39.1, 47.7) 42.4 (38.4, 46.3) 32.2 (30.2, 34.2) 19.2 (18.6, 19.9)
8th 36 1 2.8 45.0 (39.8, 50.1) 43.4 (39.1, 47.6) 32.7 (30.5, 34.9) 19.2 (18.6, 19.9)
9th 20 0 0.0 45.0 (39.8, 50.1) 43.4 (39.1, 47.6) 32.7 (30.5, 34.9) 19.2 (18.6, 19.9)
Aged more than 42 years
1st 4,420 164 3.7 (3.2, 4.3) 3.7 (3.2, 4.3) 3.7 (3.2, 4.3) 3.7 (3.2, 4.3) 3.7(3.2, 4.3)
2nd 1,578 52 3.3 (2.4, 4.2) 6.9 (5.9, 7.9) 6.9 (5.9, 7.9) 6.3 (5.4, 7.2) 4.9 (4.3, 5.6)
3rd 509 17 3.3 (1.8, 4.9) 10.0 (8.2, 11.7) 9.8 (8.1, 11.5) 8.3 (7.1, 9.6) 5.4 (4.7, 6.0)
4th 160 2 1.3 11.1 (8.8, 13.4) 10.1 (8.5, 11.8) 8.9 (7.4, 10.5) 5.5 (4.8, 6.2)
5th 67 3 4.5 15.1 (10.2, 20.0) 14.2 (10.7, 17.7) 10.7 (8.2, 13.2) 5.5 (4.8, 6.2)
6th 24 0 0.0 15.1 (10.2, 20.0) 14.2 (10.7, 17.7) 10.7 (8.2, 13.2) 5.6 (4.9, 6.3)
7th 10 2 20.0 32.1 (10.7, 53.5) 22.3 (14.0, 30.5) 15.9 (8.5, 23.2) 5.6 (4.9, 6.3)
8th 5 0 0.0 32.1 (10.7, 53.5) 22.3 (14.0, 30.5) 15.9 (8.5, 23.2) 5.6 (4.9, 6.3)
9th 4 0 0.0 32.1 (10.7, 53.5) 22.3 (14.0, 30.5) 15.9 (8.5, 23.2) 5.6 (4.9, 6.3)
a

The optimal estimate assumes that the cumulative live-birth rate in women who discontinue IVF without a live-birth, if they had continued, would have been equal to the rate in women who continued to have further IVF. That is it assumes that 0% of women who discontinued IVF did so because of poor prognosis that would have affected their live-birth success had they continued.

b

The previous oocyte yeild-adjusted estimate assumes that the cumulative live-birth rate in women who discontinued IVF, if they had continued, would have been equal to the rate in women who had the same oocyte yield in the immediately previous ovarian stimulation treatment, and who continued to have further IVF. These results suggested approximately 3% of women who discontinued did so because of poor prognosis and would have had a live-birth rate of zero, had they continued.

c

The prognostic-adjusted estimate assumes that 30% of women who discontinued IVF did so because of poor prognosis and would have had a live-birth rate of zero, had they continued.

d

The conservative estimate assumes that the cumulative live-birth rate in all women who discontinued IVF would have been zero, had they continued. That is it assumes that 100% of women who discontinued did so because of poor prognosis and would have had a live-birth rate of zero, had they continued.

Note it is not possible to calculate an age-adjusted estimate these age stratified analyses and there is too little age variation within the ages stratified groups to further adjust for age.

These are cycles for which there was fewer than six live births and for these standard errors and hence confidence intervals could not be calculated